iCo Therapeutics (iCo Therapeutics) Days Sales Outstanding : 0.00 (As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Days Sales Outstanding?

iCo Therapeutics's average Accounts Receivable for the three months ended in Mar. 2021 was $0.00 Mil. iCo Therapeutics's Revenue for the three months ended in Mar. 2021 was $0.00 Mil.

The historical rank and industry rank for iCo Therapeutics's Days Sales Outstanding or its related term are showing as below:

ICOTF's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 71.92
* Ranked among companies with meaningful Days Sales Outstanding only.

iCo Therapeutics's Days Sales Outstanding stayed the same from Mar. 2020 (0.00) to Mar. 2021 (0.00).

iCo Therapeutics Days Sales Outstanding Historical Data

The historical data trend for iCo Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Days Sales Outstanding Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Days Sales Outstanding

Get a 7-Day Free Trial

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of iCo Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, iCo Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iCo Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iCo Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where iCo Therapeutics's Days Sales Outstanding falls into.

iCo Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

iCo Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as

	Days Sales Outstanding (A: Dec. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2019 )	+	Accounts Receivable (A: Dec. 2020 ))	/	count )	/	Revenue (A: Dec. 2020 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

iCo Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2021 is calculated as:

	Days Sales Outstanding (Q: Mar. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Mar. 2021 ))	/	count )	/	Revenue (A: Mar. 2021 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

iCo Therapeutics (GREY:ICOTF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

iCo Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines